Skripsi ini menganalisis implementasi telemedicine dan regulatory sandbox di Indonesia berdasarkan Kepmenkes 1280/2023, UU 17/2023, dan Permenkes 20/2019, serta di Singapura berdasarkan Health Care Services Act (HCSA) dan National Telemedicine Guidelines (NTG). Skripsi ini disusun dengan metode penelitian doktrinal dengan tipe penelitian deskriptif-preskriptif, mengkaji telemedicine dan regulatory sandbox dengan membandingkan konsep, regulasi, dan isu hukum di Indonesia dan Singapura. Dalam hal ini, Singapura menggunakan sistem lisensi untuk telemedicine dibawah HCSA dengan NTG yang digunakan sebagai pedoman khusus. Sebelum sistem lisensi digunakan, Singapura menyelenggarakan regulatory sandbox LEAP hingga 2021, guna menyesuaikan HCSA dengan perkembangan teknologi kesehatan. Di Indonesia, telemedicine belum mempunyai pengaturan secara khusus. Meskipun sudah berkembang cukup baik melalui aplikasi berbasis smartphone yang diselenggarakan oleh health-tech company, hal ini belum sesuai dengan standar perangkat telemedicine. Kepmenkes 1280/2023 hanya mengakomodir telemedicine yang diselenggarakan melalui aplikasi berbasis smartphone, yang mana belum mendukung standarisasi telemedicine. Oleh karena itu, disarankan kepada Kementerian Kesehatan untuk mempercepat penyusunan regulasi yang sesuai dengan standar telemedicine melalui regulatory sandbox yang juga melibatkan pemangku kepentingan lain.

---

This thesis analyzes the implementation of telemedicine and regulatory sandboxes in Indonesia based on Kepmenkes 1280/2023, UU 17/2023, and Permenkes 20/2019, as well as in Singapore based on the Health Care Services Act (HCSA) and National Telemedicine Guidelines (NTG). The research employs a doctrinal methodology with a descriptive-prescriptive approach, examining telemedicine and regulatory sandboxes by comparing concepts, regulations, and legal issues in Indonesia and Singapore. In this context, Singapore uses a licensing system for telemedicine under the HCSA with NTG as specific guidelines. Before the licensing system was implemented, Singapore conducted the LEAP regulatory sandbox until 2021 to adapt the HCSA to health technology developments. In Indonesia, telemedicine does not yet have specific regulations. Although it has developed quite well through smartphone-based applications run by health-tech companies, this does not meet telemedicine equipment standards. Kepmenkes 1280/2023 only accommodates telemedicine conducted through smartphone applications, which does not support telemedicine standardization. Therefore, it is recommended that the Ministry of Health expedite the formulation of regulations that meet telemedicine standards through regulatory sandboxes involving other stakeholders.